Wei Lin
Insider Reports History
- Location
- San Diego, CA
- Signature
- /s/ Jack Anders, as Attorney-in-fact for Wei Lin
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Wei Lin:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Revolution Medicines, Inc. | Chief Medical Officer | Common Stock | 101,366 | $10,083,930 | $99.48 | 17 Mar 2026 | Direct |
| Erasca, Inc. | Chief Medical Officer | Common Stock | 315,812 | $501,983 | $1.59 | 01 Feb 2023 | Direct |
| 2seventy bio, Inc. | Director | Stock Options (Right to buy) | 24,100 | $94,713 | $3.93 | 10 Jun 2024 | Direct |
| 2seventy bio, Inc. | Director | Common Stock | 0 | $0 | $4.94 | 13 May 2025 | Direct |
| Erasca, Inc. | Chief Medical Officer | Stock Option (right to buy) | 560,000 | 01 Feb 2023 | Direct | ||
| Revolution Medicines, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 34,000 | 01 Mar 2026 | Direct | ||
| 2seventy bio, Inc. | Director | Stock Options (Right to buy) | 0 | 13 May 2025 | Direct |
Insider Reports Filed by Wei Lin
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RVMD | Revolution Medicines, Inc. | 17 Mar 2026 | 1 | -$206,223 | 4 | Chief Medical Officer | 19 Mar 2026, 18:57 |
| RVMD | Revolution Medicines, Inc. | 01 Mar 2026 | 2 | $0 | 4 | Chief Medical Officer | 03 Mar 2026, 21:10 |
| RVMD | Revolution Medicines, Inc. | 16 Sep 2025 | 1 | -$98,982 | 4 | Chief Medical Officer | 18 Sep 2025, 16:39 |
| RVMD | Revolution Medicines, Inc. | 16 Jun 2025 | 1 | -$86,551 | 4 | Chief Medical Officer | 18 Jun 2025, 16:05 |
| TSVT | 2seventy bio, Inc. | 13 May 2025 | 3 | $0 | 4 | Director | 15 May 2025, 16:34 |
| RVMD | Revolution Medicines, Inc. | 01 Mar 2025 | 2 | $0 | 4 | Chief Medical Officer | 04 Mar 2025, 19:01 |
| RVMD | Revolution Medicines, Inc. | 17 Jun 2024 | 1 | -$208,954 | 4 | Chief Medical Officer | 20 Jun 2024, 16:10 |
| TSVT | 2seventy bio, Inc. | 10 Jun 2024 | 2 | $0 | 4 | Director | 12 Jun 2024, 18:53 |
| RVMD | Revolution Medicines, Inc. | 21 Mar 2024 | 0 | $0 | 3 | Chief Medical Officer | 29 Mar 2024, 16:57 |
| TSVT | 2seventy bio, Inc. | 13 Jun 2023 | 2 | $0 | 4 | Director | 15 Jun 2023, 17:00 |
| TSVT | 2seventy bio, Inc. | 07 Mar 2023 | 2 | $0 | 4 | Director | 09 Mar 2023, 20:48 |
| TSVT | 2seventy bio, Inc. | 07 Mar 2023 | 0 | $0 | 3 | Director | 09 Mar 2023, 20:47 |
| ERAS | Erasca, Inc. | 01 Feb 2023 | 3 | +$7,169 | 4 | Chief Medical Officer | 03 Feb 2023, 07:53 |
| ERAS | Erasca, Inc. | 01 Feb 2022 | 2 | +$18,123 | 4 | Chief Medical Officer | 03 Feb 2022, 18:54 |
| ERAS | Erasca, Inc. | 15 Jul 2021 | 0 | $0 | 3 | Chief Medical Officer | 15 Jul 2021, 21:37 |